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The burden of multimorbidity 
The focus of primary health care (PHC) in developed 
countries is now largely centred on the treatment and 
management of long-term or chronic diseases. Due to 
shared risk factors and interaction among diseases, chronic 
conditions are increasingly occurring in clusters.1 In Canada, 
more than 50% of adults aged 65 years and older report 
having at least two chronic diseases.2 The co-occurrence of 
multiple chronic diseases in an individual, or multimorbidity, 
is also understood to be the norm rather than the exception 
in PHC.3 Multimorbidity is associated with reduced quality 
of life, limited functional status, polypharmacy, increased 
mortality, and high health care costs.3 Deemed an “endless 
struggle” by PHC providers, multimorbidity is becoming 
more prevalent in younger patients and is no longer 
confined to elderly populations.1,4 This phenomenon is 
pushing PHC providers and researchers alike to understand 
its multifaceted nature. A better understanding of the 
etiology behind multimorbidity can lead to a transformed 
clinical approach that will, in turn, be cost-saving in the 
long-run. To achieve this, three main components are 
necessary. 
(1) Defining and measuring multimorbidity 
Due to the relatively recent emergence of research in this 
field, the definition and measurement of multimorbidity 
remain inconsistent. While the definition has continually 
revolved around the co-existence of ≥2 chronic diseases or 
≥3 chronic diseases in an individual, no consensus exists to 
date. Literature shows that 51% of published multimorbidity 
research did not explicitly state the definition of 
multimorbidity used, adding to the mystery.5 There is also 
marked variation in the methodology of multimorbidity 
studies with respect to the type of data used, the population 
studied, and the types of chronic diseases included in the 
pool of multimorbidity.6,7 A recent comparison of three 
studies found that the prevalence levels of multimorbidity 
in a PHC setting ranged from 34% to 95%.6 Persistent 
heterogeneity hinders comparability across studies and 
limits the ability to make informed health system and 
health policy decisions.6,7 Consequently, an explicit and 
unified methodology to examine multimorbidity in PHC 
research is needed. 
(2) Building our understanding of multimorbidity 
Historically, medical research has focused on patients 
suffering from single and discrete diseases, such as diabetes 
or hypertension. However, this single-disease orientation is 
inapplicable for patients living with multimorbidity because 
of the interrelatedness of chronic diseases and common 
underlying causal mechanisms.1,8-9 For example, ongoing 
PHC research both in Canada and abroad is uncovering 
the non-random clusters of chronic diseases and clinically 
consistent multimorbidity patterns.1 We are also learning 
of the deeply entangled sociocultural causes of chronic 
diseases, with the onset of multimorbidity occurring 10 
to 15 years earlier in individuals living in deprived areas.10 
This research is creating a more nuanced understanding of 
multimorbidity, which will lead to more effective chronic 
disease prevention and management strategies.
(3) Transforming PHC clinical multimorbidity 
Key elements of our health care system have been organized 
and designed for patients with discrete diseases, including 
clinical practice guidelines and disease management 
strategies for providers. There are well-established calls 
for these elements to be renewed and restructured. 
Clinical practice guidelines have the potential to improve 
care and outcomes for those with chronic disease, but 
seldom explicitly account for patients with multimorbidity.9 
Updated clinical guidelines should be reformatted to 
synthesize the evidence for clinical recommendations,  
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while identifying synergies and contradictions of clinical 
approaches in the face of multimorbidity.9 Although it will 
admittedly not be possible to provide rigorous evidence for 
every possible combination of disease, this transformation 
will require an integrated team of professionals and a 
change from our traditional single-disease focus, facilitated 
by a patient-centred approach. Indeed, these demands 
indicate a significant undertaking and a change in the status 
quo. However, these new approaches will become much 
needed resources for our frontline PHC providers and their 
patients. 
Reorienting research and delivery in PHC
Multimorbidity has set the stage for us to reorient the 
delivery of PHC. We must harness the growing momentum 
to conduct more robust PHC research, establish a 
multidisciplinary and patient-centred approach, and 
transform the clinical management of multimorbidity 
in PHC. In the context of PHC research, an explicit and 
comprehensive definition of multimorbidity will help guide 
health system design and health policy decision-making. In 
the context of PHC delivery, there is a need to control – 
or even cope with – the tsunami of demands from these 
patients.4,6 We must reorient our thinking, from a focus on 
disease to recognizing the needs and goals of the growing 
number of patients living with multimorbidity. These 
elements are steps towards adequately responding to this 
new reality. Not only will this reorientation help our current 
PHC system cope with the complexities of multimorbidity, 
it will also help ensure that our system is responsive and 
sustainable into the future. ¾
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